IP Library › Assignment 023605/0562
Patent Assignment
Reel/Frame 023605/0562

Nunc Pro Tunc Assignment

Recorded: 2009-12-04 Pages: 13
Assignor
BAYER PHARMACEUTICALS CORPORATION
Executed: 2009-08-05
Assignee
BAYER HEALTHCARE AG
KAISER-WILHELM-ALLEE, LEVERKUSEN, 51368, GERMANY
Covered Properties (71)
1H-Pyrozolyl Derivative Compounds, for Use in Diseases Associated with the 5-HT2C Receptor
4-Sulfide/Sulfoxide/Sulfonyl-1H-Pyrazolyl Derivative Compounds, for Use in Diseases Associated with the 5-HT2C Receptor
Indolyl Pyrazinone Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Substituted Tetrahydrobenzothienopyrimidinamine Compounds Useful for Treating Hyper-Proliferative Disorders
Methods for Treating Diabetes and Related Disorders Using PDE10A Inhibitors
Indolyl-Thienopyrazinone Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Selective Neuropeptide Y2 Receptor Agonists
2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
Improved Aprotinin Variants
Novel Heterocycles
Novel Heterocycles
Novel Pyrimidothienoindazoles
1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents
1-Methyl-1H-Pyrazole-4-Carboxamides Useful as Cancer Chemotherapeutic Agents
Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines Igf-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases
Pyrazolyl Urea Derivatives Useful in the Treatment of Cancer
Substituted Pyrimidine Derivatives Useful in the Treatment of Cancer and Other Disorders
Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof
Pyridonecarboxamide Derivatives Useful in Treating Hyper-Proliferative and Angiogenesis Disorders
Substituted 2,3-Dihydroimidazo[1,2-C]Quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent: 5,919,901 →
Application: 08/630,118 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent: 5,965,392 →
Application: 08/838,399 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent: 6,207,799 →
Application: 09/235,839 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent: 6,368,824 →
Application: 09/327,035 →
Human Neuropeptide Y-Like G Protein-Coupled Receptor
Patent: 6,927,041 →
Application: 09/899,532 →
Publication: US 2002/0048791
4-Amino-5,6-Substituted Thiopheno [2,3-D] Pyrimidines, Pharmaceutical Compositions Containing the Same, and Their Use in the Treatment or Prevention of PDE7B-Mediated Diseases and Conditions
Patent: 6,849,638 →
Application: 10/136,575 →
Publication: US 2003/0119829
Imidazopyrimidine Derivatives and Triazolopyrimidine Derivatives
Patent: 6,911,443 →
Application: 10/258,628 →
Publication: US 2004/0054179
1H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
Application: 10/499,786 →
Publication: US 2005/0119246
4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
Application: 10/499,789 →
Publication: US 2005/0119489
Fused Azole-Pyrimidine Derivatives
Patent: 7,511,041 →
Application: 10/527,376 →
Publication: US 2006/0128732
Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Application: 10/534,215 →
Publication: US 2006/0004011
Substituted Tetrahydrobenzothienopyrimidinamine Compounds Useful for Treating Hyper-Proliferative Disorders
Patent: 7,238,701 →
Application: 10/557,090 →
Publication: US 2006/0293322
Methods for treating diabetes and related disorders using pde10a inhibitors
Application: 10/564,680 →
Publication: US 2007/0032404
Selective neuropeptide y2 receptor agonists
Application: 10/576,674 →
Publication: US 2009/0105122
Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis
Application: 10/579,938 →
Publication: US 2007/0105851
Human neuropeptide Y-like G protein-coupled receptor
Application: 11/133,283 →
Publication: US 2005/0221436
Neuropeptide Y receptor Y5 and nucleic acid sequences
Application: 11/335,119 →
Publication: US 2006/0189530
2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
Application: 11/630,850 →
Publication: US 2008/0293696
Aprotinin Variants
Application: 11/659,434 →
Publication: US 2009/0005297
Pyrimidinothienoindazoles Useful for the Treatment of Hyperproliferative Disorders
Patent: 8,207,172 →
Application: 11/662,416 →
Publication: US 2011/0172224
Novel Heterocycles
Patent: 7,750,017 →
Application: 11/665,313 →
Publication: US 2008/0132497
Novel Pyrimidothienoindazoles
Patent: 7,511,048 →
Application: 11/666,362 →
Publication: US 2007/0299066
1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents
Application: 11/885,104 →
Publication: US 2009/0023753
1-Methyl-1h-pyrazole-4-caroxamides useful as cancer chemotherapeutic agents
Application: 11/921,531 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Application: 60/014,969 →
Human Neuropeptide Y-like G protein-coupled receptor
Application: 60/216,523 →
4-Amino-5, 6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7 B-mediated diseases and conditions
Application: 60/287,629 →
1H-pyrazolyl derivatives compounds, their use in diseases associated with the 5-HT2C receptor
Application: 60/344,149 →
Supersonic revolving nozzle
Application: 60/344,749 →
Quinoxalinone derivatives useful for treating cancer
Application: 60/425,490 →
Quinoxalinone indole derivatives useful for treating cancer
Application: 60/460,915 →
Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders
Application: 60/484,202 →
Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
Application: 60/490,335 →
Methods of treating diabetes and related disorders using PDE10A inhibitors
Application: 60/491,730 →
Indolyl-thienopyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Application: 60/524,359 →
Novel selective neuropeptide Y2 agonists
Application: 60/525,482 →
2-Aminoarylcarboxamides useful as cancer chemotherapeutic agents
Application: 60/582,326 →
Aprotinin variants
Application: 60/587,655 →
Novel heterocycles
Application: 60/603,398 →
Novel heterocycles
Application: 60/607,281 →
Novel heterocycles
Application: 60/619,066 →
Novel pyrimidothienoindazoles
Application: 60/622,640 →
1,3-Thiazole-5-carboxamides useful as cancer chemotherapeutic agents
Application: 60/658,985 →
1-Methyl-1H-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
Application: 60/687,454 →
Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
Application: 60/733,094 →
Pyrazolyl urea derivatives useful in the treatment of cancer
Application: 60/736,400 →
Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
Application: 60/752,200 →
Tetrahydropyridothienopyrimidines
Application: 60/784,146 →
Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogensis disorders
Application: 60/801,700 →
Substituted 2,3-dihydroimidazo[1,2-c]quinazolin derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Application: 60/873,090 →
Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
Application: 60/928,789 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Nunc Pro Tunc Assignment Jan 27, 2010
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 023854/0934 →
Change of Name Sep 26, 2017
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 044013/0520 →